By Michael Erman and Leroy Leo (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for...
(Reuters) - Novavax (NASDAQ:NVAX) Inc said on Monday its longtime chief executive officer, Stanley Erck, would retire and be succeeded by industry veteran John Jacobs, at a time...
Robust pipeline of over 90 drugs, vaccinations make up 38% of revenues Reported its highest quarterly sales in history in Q2 2022 Recession-resistant due to COVID-19 vaccine...
NVAX stock is down 16% this week, bringing its 12-month loss to over 88%. The company is struggling to meet revenue expectations from its Covid-19 vaccine candidate. Demand for...
Investing in mid-cap stocks is essential for investors who prefer a diversified portfolio. These stocks offer a middle ground with regard to the risks and rewards when compared to...
Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).
| Average | 55.33 (+398.95% Upside) |
| High | 110.00 |
| Low | 13.00 |
| Price | 11.09 |
| No. of Analysts | 6 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 128.64 | 129.55 | 127.78 | -1.17 | -0.90% | 1.38M | NYSE | |||
| 82.33 | 83.80 | 82.14 | -3.19 | -3.73% | 14.13M | NASDAQ | |||
| 83.68 | 86.28 | 83.22 | -2.41 | -2.80% | 52.81M | NASDAQ | |||
| 194.76 | 198.17 | 189.92 | +4.78 | +2.52% | 185.21M | NASDAQ | |||
| 61.08 | 62.17 | 60.11 | -2.95 | -4.61% | 12.36M | NYSE | |||
| 41.28 | 41.59 | 40.90 | -0.23 | -0.55% | 15.52M | NYSE | |||
| 3.16 | 3.36 | 2.79 | +0.15 | +4.98% | 76.36M | NYSE | |||
| 229.44 | 230.26 | 228.04 | -0.69 | -0.30% | 3.24M | NYSE | |||
| 28.72 | 29.32 | 28.47 | -0.35 | -1.20% | 7.48M | NASDAQ | |||
| 23.86 | 24.88 | 21.77 | +1.61 | +7.24% | 8.53M | NYSE | |||
| 163.36 | 164.85 | 163.10 | -1.25 | -0.76% | 7.01M | NYSE | |||
| 27.89 | 28.09 | 27.08 | +0.41 | +1.49% | 21.03M | NYSE | |||
| 151.73 | 153.10 | 150.78 | -2.77 | -1.79% | 67.99M | NASDAQ | |||
| 136.18 | 136.32 | 134.95 | -0.76 | -0.56% | 4.83M | NYSE | |||
| 11.96 | 12.13 | 11.60 | +0.34 | +2.93% | 26.10M | NASDAQ |